Internationally Renowned UCSD Physician-Researcher Chosen as Distinguished Scientist by American Heart Association

 

December 03, 2010  |  

Michael H.Criqui, MD, MPH, FAHA, professor and chief of the Division of Preventive Medicine in the Department of Family and Preventive Medicine at the University of California, San Diego was honored as a Distinguished Scientist by the American Heart Association (AHA) at this year’s AHA Scientific Sessions in Chicago, Illinois.  This is the highest honor given by the AHA.

Michael Criqui

Dr. Michael Criqui was named 1 of 5 AHA Distinguished Scientists for 2010

In 2003, the American Heart Association created a Distinguished Scientist designation to honor AHA/ASA members who have made extraordinary contributions to cardiovascular and stroke research.   This title recognizes seminal research work that has importantly advanced the understanding and management of cardiovascular disease or stroke.

Criqui is one of five honorees this year to join the ranks of 65 other preeminent researchers and scientists.  He is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of peripheral arterial disease, subclinical atherosclerosis and peripheral venous disease.  Criqui has published over 385 manuscripts and book chapters and has been an invited lecturer at numerous national and international meetings.

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu


Related Specialties



Media Contact

Share This Article


Related News

9/10/2019
UC San Diego researchers say that measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increas ...
9/5/2019
The San Diego Center for AIDS Research (CFAR) at University of California San Diego has been awarded planning grants to help the federal government achieve its goal of reducing the number of new HIV i ...
9/3/2019
A new University of California San Diego School of Medicine study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer’s ability to survive chemotherapy.
9/3/2019
CARB-X, an international funder of efforts to fight antimicrobial resistance, is awarding up to $15 million to develop a strep throat vaccine based on original research at UC San Diego.



Follow Us